Why physicians join our rheumatology community
Sermo’s rheumatology physician network provides practicing rheumatologists with a secure, peer-driven platform to discuss the latest in biologic therapies, JAK inhibitors, connective tissue diseases, and crystal arthropathies. Whether you’re dealing with refractory RA, complex lupus nephritis, or vasculitis, Sermo connects you to peers facing similar challenges—from navigating payer restrictions and prior authorizations to managing complex comorbidities and interpreting ambiguous serologies.
Connect with rheumatology specialist peers
Tap into one of the largest online communities of practicing rheumatologists managing everything from common arthritis to rare autoimmune syndromes.
Engage in real-time clinical discussions
Contribute to peer-driven conversations on complex diagnostic dilemmas, management of flares, and evolving treatment guidelines.
Discuss long-term patient care strategies
Join discussions on managing chronic inflammatory conditions, coordinating multidisciplinary care, and guiding patients through lifelong treatment journeys.
Stay up to date on rheumatology research
Discover the latest conversations and breakthroughs in targeted synthetic DMARDs, biosimilars, and novel pathways—keeping you at the forefront of your field.
Make confident treatment decisions
Access peer-reviewed drug ratings to support informed treatment decisions, grounded in real-world physician experience.
Collaborate on rheumatology patient care
Exchange frontline experiences, tapering strategies, and clinical protocols with peers in a secure, physician-only community.
Earn money sharing your rheumatology expertise
Learn why surveys are worth it for rheumatologists and tackle topics such as:
- Surveys on the adoption of biosimilars in clinical practice
- Opinion polls on safety concerns regarding JAK inhibitors
- Research studies around patient reported outcomes in Psoriatic Arthritis
Access rheumatology drug insights from peers
Get practical, peer-reviewed information on rheumatic treatments:
- Detailed safety profiles of biologics and small molecules
- Comparative efficacy assessments
- Real-world tolerability experiences
- FDA approval timelines for new therapies and practical use cases
Learn from rheumatology articles and case studies
Discover strategies and real-world advice based on insights from physicians on Sermo.
- Navigating difficult conversations about chronic pain and fatigue
- Showing empathy when diagnosing lifelong autoimmune conditions
- Overcoming barriers to access for high-cost infusion therapies
- Emerging treatments for systemic sclerosis and myositis
Hear from fellow physician peers
Drug Ratings program has been very resourceful to me to get a clue on medicines which I have little experience with but may like to use in the management of my clients. Thank you, Sermo!
It has enlightened me about my practice decisions, and supported me to get quick reliable help in solving mystery cases.
It helps a lot to solve clinical cases. I love participating in the comments as well as in the promotions. Of course I always recommend Sermo to my colleagues. Excellent platform.
Frequently asked questions
Sermo’s rheumatology community regularly shares updates and discussions around FDA/EMA approvals, trial outcomes, and real-world experiences with new biologics, JAK inhibitors, and biosimilars.
Yes. Our drug ratings feature allows rheumatologists to review and compare medications across efficacy, safety, and tolerability—based on real-world experiences.
Absolutely. Sermo members frequently share information related to clinical trial eligibility for conditions like SLE, PsA, and rare vasculitides, as well as patient recruitment challenges.
Yes. Whether you are in a university research setting or a private infusion center, Sermo provides a space to share your expertise and learn from others managing similar caseloads.
You’ll find case studies ranging from diagnostic mimics of rheumatic disease to management of complex overlap syndromes and pregnancy in autoimmune patients.
Yes. Many of the discussions on Sermo focus on the burden of prior authorizations, documentation requirements, and the business side of running a rheumatology practice.
Sermo enables real-time collaboration. Post a case summary or de-identified images anonymously and receive input within hours—helping you make confident decisions when clarity matters most.
Sermo is designed to complement—not replace—professional societies and formal networks. It gives physicians a place for real-time peer discussion, specialty-specific insights, and opportunities to contribute to paid research, all within a physician-only community that fits easily into day-to-day practice.
If you’d like to see how Sermo compares with other physician networks, explore how we differ from Doximity or M3 Global.
Start your rheumatology journey on Sermo
Become part of a dynamic rheumatology physician network of over 15,000 members dedicated to improving quality of life for patients and advancing care through peer collaboration and expert insights.
